000019253 000__ 01747cam\a22003375i\4500
000019253 001__ 19253
000019253 003__ SzGeWIPO
000019253 005__ 20210318104739.0
000019253 008__ 910504s1987\\\\dcu\\\\\r\\\\u000\0\eng\d
000019253 035__ $$a(wipo)(CD )91/0632
000019253 035__ $$a(OCoLC)1159949521
000019253 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000019253 043__ $$an-us---
000019253 084__ $$aG 252 NEW(1)
000019253 090__ $$c20487$$d20487
000019253 1102_ $$aOffice Of Technology Assessment (OTA),$$eissuing body.
000019253 24510 $$aNew Developments in Biotechnology :$$b1 : Ownership of Human Tissues and Cells /$$cOffice Of Technology Assessment (ota).
000019253 264_1 $$aWashington, Dc :$$bOffice Of Technology Assessment (OTA),$$c1987.
000019253 300__ $$a168 pages ;$$c[28] cm
000019253 336__ $$atext$$btxt$$2rdacontent
000019253 337__ $$aunmediated$$bn$$2rdamedia
000019253 338__ $$avolume$$bnc$$2rdacarrier
000019253 500__ $$aPrice : U. S. Department of Commerce : National Technical Information Service (NTIS); This publication is reproduced and supplied by the NTIS United Kingdom Managing Dealer Microinfo Ltd., Alton, Hampshire, UK; Order Reference : D 3386.
000019253 5050_ $$a1. Summary, policy issues, and options for congressional action; 2. Introduction; 3. the technologies; 4. The interested parties; 5. Legal considerations; 6. Informed consent and disclosure; 7. Economic consideration; 8. Ethical considerations; Appendix : A. Code of federal regulations, part 46, subpart A; B. Acknowledgments; C. Glossary; Index;.
000019253 650_0 $$aPatents$$zUnited States.
000019253 650_4 $$aPATENTS : PATENTABILITY : BIOTECHNOLOGY : UNITED STATES
000019253 651_0 $$aUnited States$$xCommerce$$xLaw and legislation.
000019253 903_0 $$aOTA-BA-337$$v1
000019253 942__ $$cMON
000019253 952__ $$w2006-11-03$$p1991-0632$$r20.00$$u25530$$bMAIN$$10$$kG 252 NEW(1)$$v1991-05-04$$ztagged$$71
000019253 980__ $$aBIB
000019253 999__ $$c20487$$d20487